Back to today’s briefing

Story perspectives

GLP-1 Drugs Revolutionize Weight Loss, But Behavioral Change Still Key

1/30/2025

47 5

Summary

Story summary

GLP-1 receptor agonists are revolutionizing obesity treatment, enabling patients to shed up to 22% of their weight. Yet, they fall short in tackling the root causes, such as behavioral changes. Experts emphasize the importance of motivational interviewing, which empowers patients and strengthens the bond with healthcare providers, paving the way for lasting weight loss success.

1 of 1

Story summary

GLP-1 receptor agonists are revolutionizing obesity treatment, enabling patients to shed up to 22% of their weight. Yet, they fall short in tackling the root causes, such as behavioral changes. Experts emphasize the importance of motivational interviewing, which empowers patients and strengthens the bond with healthcare providers, paving the way for lasting weight loss success.